Trials / Unknown
UnknownNCT04333004
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Xiaorong Dong · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pembrolizumab Combined With Chemotherapy | Pembrolizumab and chemotherapy are carried out at the same time for every 3 weeks |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-04-01
- Completion
- 2022-04-01
- First posted
- 2020-04-03
- Last updated
- 2020-04-03
Source: ClinicalTrials.gov record NCT04333004. Inclusion in this directory is not an endorsement.